Metformin in cancer prevention and therapy

[Steroidify Rep]

The prevalence of diabetes is dramatically increasing worldwide. The  results of numerous epidemiological studies indicate that diabetic  population is not only at increased risk of cardiovascular  complications, but also at substantially higher risk of many forms of  malignancies. The use of metformin, the most commonly prescribed drug  for type 2 diabetes, was repeatedly associated with the decreased risk  of the occurrence of various types of cancers, especially of pancreas  and colon and hepatocellular carcinoma.

Read more:

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4200668/

Click here to purchase metformin: